Apixaref-5

Apixaref-5 contains Apixaban 5mg, an anticoagulant used to reduce the risk of stroke and blood clots in patients with atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). Trusted formulation for effective and predictable blood thinning therapy.

Description

Apixaref-5 (Apixaban 5mg) is a prescription oral anticoagulant that helps prevent and treat blood clots. It is commonly prescribed for:

  • Reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation

  • Treatment and prevention of DVT (Deep Vein Thrombosis) and PE (Pulmonary Embolism)

  • Post-surgical clot prevention (hip/knee replacement)

Apixaref-5 belongs to a class of medications called Factor Xa inhibitors, which work by blocking certain clotting proteins in the blood, offering predictable anticoagulation with minimal dietary restrictions.


🔹Uses:

  • Atrial fibrillation (non-valvular)

  • DVT / PE treatment and prevention

  • Post-operative thromboprophylaxis

🔹Dosage:

As prescribed by the physician. Do not adjust dose without consultation.

🔹Benefits:

  • Predictable response

  • No routine blood monitoring required

  • Lower risk of major bleeding compared to warfarin

🔹Directions for Use:

Swallow the tablet with water, with or without food, as directed by your doctor.


💼 For Franchise & Third Party Manufacturing:
We welcome pharma distributors and healthcare professionals to collaborate with us. For PCD Pharma Franchise or Contract Manufacturing inquiries for Apixaref-5, contact us today!